An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs

Masatoshi HirayamaDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;Department of Oral and Maxillofacial Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Yusuke TomitaDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;Department of Respiratory Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Akira YunoDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;Department of Oral and Maxillofacial Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Hirotake TsukamotoDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Satoru SenjuDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Yuya ImamuraDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Mohammad Abu SayemDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh

Atsushi IrieDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Yoshihiro YoshitakeDepartment of Oral and Maxillofacial Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Daiki FukumaDepartment of Oral and Maxillofacial Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Masanori ShinoharaDepartment of Oral and Maxillofacial Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Akinobu HamadaDepartment of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan;Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

Hirofumi JonoDepartment of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan;Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

Eiji YubaDepartment of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, Sakai, Japan

Kenji KonoDepartment of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, Sakai, Japan

Koji YoshidaOncoTherapy Science Incorporation, Research and Development Division, Kawasaki, Japan;Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University of Tokyo, Tokyo, Japan;AstraZeneca K.K., Oncology, Medical, Tokyo, Japan

Takuya TsunodaOncoTherapy Science Incorporation, Research and Development Division, Kawasaki, Japan;Merck-Living Innovation, Tokyo, Japan

Hideki NakayamaDepartment of Oral and Maxillofacial Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Yasuharu NishimuraDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, JapanCorrespondence[email protected]

show all

An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date